Skip to main content
Total Market Cap: $43,732,033,605 Volume (24h): $739,350,421

Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc. (CNBX) logo
Rank 68
About

Based in the US, Cannabics Pharmaceuticals focus is the use of tailored cannabinoid-based therapies to support cancer patients. In conjunction with artificial intelligence and drug screening tools, they aim to provide a personalised service. A licensed facility in Israel conducts research and development. Their central office is based in Bethesda, Maryland.

Website
$0.2435
USD
2.53%
Market cap
$32,892,087
Total volume
$26,235
Shares outstanding
135,080,441
Reserved shares
764,919,559
Rank 68
Website
About

Based in the US, Cannabics Pharmaceuticals focus is the use of tailored cannabinoid-based therapies to support cancer patients. In conjunction with artificial intelligence and drug screening tools, they aim to provide a personalised service. A licensed facility in Israel conducts research and development. Their central office is based in Bethesda, Maryland.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
OTC
CNBX
$26,235
100%
$0.2435
Chart
Social media
Tweets by @cannabics1
Cannabics Pharmaceuticals Inc.

Share widget

Copy widget code
Subscribe to our newsletter